IP Library Granted Patent US 8,318,951
Granted Patent B2
US 8,318,951 · App. 13/116,574 · Granted Nov 27, 2012

Stem cell differentiating agents and uses therefor

Assignee: The Board of Regents of the University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,951
App. No.
13/116,574
Granted
Nov 27, 2012
Kind
B2
Abstract

The present invention relates to screens for compounds that can induce stem cell differentiation. In addition, isoxazoles and sulfonyl hydrazones are identified as general classes of compounds that can induce differentiation of stem cells into cells of neuronal and cardiac fate, respectively.

Claims (4)

1. A compound having the formula:

wherein X is NH, Y is O and R is substituted or unsubstituted C 1 -C 6 alkenyl or a substituded or unsubstituted C 2 -C 6 alkynyl.

2. The compound of claim 1 , wherein R is a substituted or unsubstituted C 2 -C 6 alkenyl.

3. The compound of claim 1 , wherein R is a substituted or unsubstituted C 2 -C 6 alkynyl.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 21, 2011
From: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026468/0561 →
Continuity (4)
Division 12183884 · Jul 31, 2008
Continuation In Part 11974479 · Oct 12, 2007
Provisional Application 60953182 · Jul 31, 2007
Related Publication 20120029200A1 · Feb 2, 2012